Osteopore Limited

ASX:OSX ISIN:AU0000053324

Ostepore LimitedOsteopore Limited (ASX:OSX) is a global medical technology company founded in Singapore and listed in Australia that commercialises products designed to enable natural bone healing across multiple therapeutic areas. Osteopore's patented technology fabricates specific microstructured scaffolds for bone regeneration through 3D printing and bioresorbable material. Osteopore's patent-protected scaffolds are manufactured using a proprietary manufacturing technique with a polymer that naturally dissolves over time to only allow natural and healthy bone tissue, significantly reducing the post-surgery complications commonly associated with permanent bone implants. Our 3D printing technology is unique to Osteopore.

 
    

News

Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market

🕔5/12/2025 4:35:33 PM 1821

Australian-Singaporean regenerative medicine company Osteopore Limited (ASX:OSX) is pleased to announce that the Company has secured a non-exclusive 3-year distribution arrangement with Kelyniam Global, Inc

Read Full Article
###

988 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 27) (Last 30 Days: 110) (Since Published: 988) 

Company Data

    Headquarters
  • Level 5, 191 St. Georges Terrace
    Perth WA 6000
    Australia
  • Telephone
  • +61 2 8072 1400 
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.osteopore.com/

Company Reports

More News Results

  • 2025/09/11: Change in substantial holding*
  • 2025/09/09: OSX collaborates with TTSH to develop novel implant for AVN*
  • 2025/09/04: Change in substantial holding*
  • 2025/09/03: Becoming a substantial holder*
  • 2025/09/01: OSX Invests AUD 0.5m in Cellular Regenerative Medicine*
  • 2025/08/29: Half Yearly Report and Accounts*
  • 2025/08/11: Ceasing to be a substantial holder*
  • 2025/08/08: Change in substantial holding*
  • 2025/08/08: OSX & Universiti Malaya initiate dental bone healing trial*
  • 2025/08/06: Change in substantial holding*
*refer to company website

Presentations

Download Presentation

Social Media